Econazole Topical Dosage

Medically reviewed by Drugs.com. Last updated on Feb 1, 2024.

Usual Adult Dose for Tinea Corporis

Topical cream: Apply sufficient amount to cover affected areas once a day.
Duration of therapy: 2 weeks

Comments:

• Most patients have early symptom relief and clinical improvement may be seen fairly soon after start of therapy; tinea cruris and corporis should be treated for 2 weeks to reduce possible recurrence.
• If no clinical improvement after the treatment period, diagnosis should be reconsidered.
• Clinical and mycological clearing of tinea versicolor usually seen after 2 weeks of therapy.

Uses: For the topical treatment of tinea cruris and tinea corporis due to Trichophyton rubrum, T mentagrophytes, T tonsurans, Microsporum canis, M audouini, M gypseum, and Epidermophyton floccosum; for the treatment of tinea versicolor

Usual Adult Dose for Tinea Cruris

Topical cream: Apply sufficient amount to cover affected areas once a day.
Duration of therapy: 2 weeks

Comments:

• Most patients have early symptom relief and clinical improvement may be seen fairly soon after start of therapy; tinea cruris and corporis should be treated for 2 weeks to reduce possible recurrence.
• If no clinical improvement after the treatment period, diagnosis should be reconsidered.
• Clinical and mycological clearing of tinea versicolor usually seen after 2 weeks of therapy.

Uses: For the topical treatment of tinea cruris and tinea corporis due to Trichophyton rubrum, T mentagrophytes, T tonsurans, Microsporum canis, M audouini, M gypseum, and Epidermophyton floccosum; for the treatment of tinea versicolor

Usual Adult Dose for Tinea Versicolor

Topical cream: Apply sufficient amount to cover affected areas once a day.
Duration of therapy: 2 weeks

Comments:

• Most patients have early symptom relief and clinical improvement may be seen fairly soon after start of therapy; tinea cruris and corporis should be treated for 2 weeks to reduce possible recurrence.
• If no clinical improvement after the treatment period, diagnosis should be reconsidered.
• Clinical and mycological clearing of tinea versicolor usually seen after 2 weeks of therapy.

Uses: For the topical treatment of tinea cruris and tinea corporis due to Trichophyton rubrum, T mentagrophytes, T tonsurans, Microsporum canis, M audouini, M gypseum, and Epidermophyton floccosum; for the treatment of tinea versicolor

Usual Adult Dose for Tinea Pedis

Topical cream: Apply sufficient amount to cover affected areas once a day.
Topical foam: Should be applied to cover affected areas once a day
Duration of therapy: 4 weeks

Comments (topical cream):

• Most patients have early symptom relief and clinical improvement may be seen fairly soon after start of therapy; should treat for 1 month to reduce possible recurrence
• If no clinical improvement after the treatment period, diagnosis should be reconsidered.

Uses:

• Topical cream: For the topical treatment of tinea pedis due to T rubrum, T mentagrophytes, T tonsurans, M canis, M audouini, M gypseum, and E floccosum
• Topical foam: For the treatment of interdigital tinea pedis due to T rubrum, T mentagrophytes, and E floccosum

Usual Adult Dose for Cutaneous Candidiasis

Topical cream: Apply sufficient amount to cover affected areas twice a day.
Duration of therapy: 2 weeks

Comments:

• Most patients have early symptom relief and clinical improvement may be seen fairly soon after start of therapy; should treat for 2 weeks to reduce possible recurrence
• If no clinical improvement after the treatment period, diagnosis should be reconsidered.

Use: For the treatment of cutaneous candidiasis

Usual Pediatric Dose for Tinea Pedis

12 years or older:
Topical foam: Should be applied to cover affected areas once a day
Duration of therapy: 4 weeks

Use: For the treatment of interdigital tinea pedis due to T rubrum, T mentagrophytes, and E floccosum

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:

• Topical Cream: Hypersensitivity to the active component or any of the ingredients
• Topical Foam: None

Safety and efficacy of the topical cream and foam have not been established in patients younger than 18 and 12 years, respectively.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

• Only use topically; not for ophthalmic, oral, or intravaginal use.
• Consult the manufacturer product information of the topical foam for administration instructions.

Storage requirements:

• Store at controlled room temperature 20C to 25C (68F to 77F)
• Topical foam: Excursions permitted to 15C to 30C (59F to 86F); do not refrigerate or freeze; do not expose container to heat and/or store at temperatures above 49C (120F), even if empty; do not store in direct sunlight.

Patient advice:

• Stop using this drug if reaction suggestive of chemical irritation or sensitivity develops.
• Read the US FDA-approved patient labeling (Patient Information) for the topical foam.
• Wash hands after applying the topical foam; avoid contact with the eyes, mouth, and vagina.
• Avoid heat, flame, and smoking during and immediately after application of the topical foam.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer